The present invention relates to the 3-[N-(2-mercaptopropionyl-amino-acetyl)]-tetrahydro-thiazolyl-4-carboxylic acid, a process for its preparation characterized by reacting an activated derivative of benzoylmercapto-propionylglycine with a metal salt of 4-carboxy-thiazolidine and subsequent debenzoylation, and pharmaceutical compositions containing it, endowed with a marked inhibitory activity of the angiotensin converting enzyme (ACE).
本发明涉及 3-[N-(2-巯基丙酰基-
氨基-乙酰基)]-四氢-
噻唑-4-羧酸,其制备方法的特点是将苯甲酰巯基丙酰基甘
氨酸的活化衍
生物与 4-羧基
噻唑烷的
金属盐反应,然后进行去苯甲酰化,本发明还涉及含有该物质的药物组合物,该药物组合物具有明显的
血管紧张素转换酶(ACE)抑制活性。